Background: Matrix metalloproteinases (MMPs) are important enzymes in the tumor
Introduction
Cervical cancer is etiologically associated with infection with high-oncogenic risk human papillomavirus (HPV) (1) . This tumor has the capacity to metastasize to distant tissues and organs, a fact strongly associated with failure of cervical cancer treatment. The evolution of metastasis is a multistep process and its initial stages can be identified in the pre-neoplasic phase (2) . Transformation of a noninvasive cervical neoplasia into an invasive cervical carcinoma requires the migration of epithelial cells through the subjacent extracellular matrix, a process in which the matrix metalloproteinases (MMPs) play a critical role by degrading extracellular matrix components (3, 4) .
MMPs are zinc-dependent endopeptidases involved in various physiological and pathological processes including tissue remodeling, development and regulation of inflammation (5, 6) . During carcinogenesis, these enzymes promote changes in the stroma and microenvironment contributing to tumor progression (5-7). Furthermore, MMPs are also dependent on local equilibrium with its physiological inhibitors, such as the RECK protein (Reversion-inducing Cysteine-rich protein with Kazal motifs), which regulates MMP-2 and MMP-9 activities (4,7).
Overexpression of MMP-2 and MMP-9 has been shown to occur in invasive cervical carcinoma and high-grade cervical lesions (3, 8, 9) .We have previously shown 2 than HPV-negative cell lines. MMP-9 was expressed at very low levels in both HPVnegative and HPV-positive cell lines (10) . In order to analyze MMPs status in a system that reproduces in vivo conditions, we have previously developed organotypic epithelial cultures with keratinocytes expressing HPV 16 oncoproteins. We have demonstrated that HPV 16 E7 induces pro-MMP-9 activity, and that E6 and E7 coexpression downregulates RECK protein levels (11) . This latter study also demonstrated that, even in small number of clinical samples, there is an inverse correlation between RECK expression and degree of cervical lesion. Furthermore, previous work from our group demonstrated the association between high-grade cervical lesions and high expression of MMP-9 in conventional Pap-smears, especially when the patient had concomitant genital infection (12) .
Clinical studies have shown an association between high-grade cervical intraepithelial neoplasia and Chlamydia trachomatis infection (13) (14) (15) (16) . Considering that concomitant genital infections have been assumed to be risk factors for HPV persistence (14) , we hypothesized that infection-induced cervical inflammation were capable of influencing the carcinogenic process driven by HPV. One can consider the role of MMPs in inflammatory process, since the involvement of these enzymes has already been demonstrated in organotypic cultures of fallopian tube infected in vitro by C.
trachomatis (17) and in the pathology of ocular trachoma (18) . However, within the context of cervical carcinogenesis, this possible relationship has not yet been elucidated.
It is biological plausible that chronic infection by C. trachomatis causes an unresolved cervical inflammation that may lead to tissue damage, involving an interplay between HPV, MMPs and their inhibitors. Therefore, in the present study we evaluated the role of MMP-9 and RECK expression in cervical lesions and genital infections.
Materials and Methods

Subject's inclusion and sample collection
This cross-sectional study included 332 women attending the CAISM Women's After signing the informed consent form, women were submitted to a specular examination for the collection of cervical samples, which were preserved partly in Surepath® vials (BD Surepath TM , Pap test) for liquid-based cytology (LBC), RNA and DNA extraction, and partly in sterile saline medium for cervical infections diagnosis.
We also collected a cervical smear to perform a GRAM-stained bacterioscopy.
An eight-milliliter fraction of the cervical sample collected in the Surepath® vial was centrifuged twice with the addition of 4 mL of gradient wash buffer. The resulting cellular pellet was suspended in 2 mL of Surepath® medium. From this cellular suspension, 200 µL were used in order to prepare the LBC slides, 200 µL were used for DNA extraction (for HPV genotyping) and 200 µL for RNA extraction (for analysis of gene expression).
Immunocytochemistry for MMP-9 and RECK evaluation in LBC slides
Liquid based cytology (LBC) slides were used to determine the expression of MMP-9 and RECK by immunocytochemistry analysis. In order to prepare the LBC slides, we used the automated PrepStain® system (TriPath Imaging, Inc., Burlington, NC). As a positive control of MMP-9 labelling, we used the HT1080 cell line derived from human fibrossarcoma (American Type Culture Collection, Manassas, VA, USA), which was chosen because it is known to be abundant in MMP-9. As a positive control for RECK labelling, we used primary human fibroblasts extracted from human foreskin 
Criteria for analyzing immunocytochemistry for MMP-9 and RECK in LBC slides
In order to analyze the immunocytochemistry slides, we adapted the criteria described by Li et al. (9) . We performed a blind test in which the observer was not informed of the diagnosis of any cervical lesions. The slides were analyzed at 400x magnification using a light microscope. Cells were counted and classified as "positive" or "negative" according to DAB chromogen staining: brown stained cells were considered as "positive" regardless of the intensity of the color (pale-yellow, brown or yellow-brown), and blue stained cells (hematoxylin only) were considered "negative".
Counting was performed in two distant random fields, avoiding the specimen edges. In case of discrepant scores between these two fields, a third field was counted. Slides grading was performed as follows: score 1 -0 to 25% of DAB stained squamous cells; score 2 -26 to 50% of DAB stained squamous cells; score 3 -51 to 75% of DAB stained squamous cells; score 4 -more than 75% of DAB stained squamous cells. Both atypical and typical squamous cells were considered in the counting.
At first, the analysis was performed by two independent observers (PCP and MGD) and, in case of disagreement, a third observer (MZ) was consulted. Scores 1 and 2 were considered as negative or mild expression, and scores 3 and 4 were considered as moderate or accentuated expression.
Real-time quantitative PCR (RT-qPCR) technique for evaluation of MMP-9 and RECK expression in cervical samples
Total RNA was extracted from cervical samples of four women from the control group (no neoplasia/CIN1) and from eleven women in the case group (CIN2/ CIN3/ SCC) using Trizol® reagent (Invitrogen, Carlsbad, CA, USA). RNA samples were quantified by UV light spectrophotometer at 260 nm (ND-1000-NanoDropWilmington, DE, USA) and RNA quality was verified by the A 260 /A 280 ratio. cDNA was synthesized from 1µg RNA using the Reverse Transcription c-DNA High-capacity® kit (4388813, AB-Applied Biosystems, Warrington, UK). RT-qPCR was carried out using Taqman® specific primers for the genes of interest (MMP-9: Hs00234579-m1, RECK:
Hs01019179-m1, Applied Biosystems, Warrington, UK). The assay was performed using ABI Prism® 7500 Sequence Detection System equipment (Applied Biosystems, New Jersey, USA), under the following conditions: activation of the AmpErase®UNG enzyme at 50°C for 2 minutes, followed by initial denaturation at 95°C for 10 minutes, Positive controls for all genital infections were derived from positive clinical samples diagnosed by reference methods, including culture and/or single PCR (sPCR) (22) .
Human β-globin-specific primers GH20/PC04 were used as internal controls for amplification and DNA integrity. The diagnosis of infections by multiplex PCR was not determined in 47 samples because of inadequate DNA internal control (β -globin).
GRAM stained bacterioscopy
The GRAM-stained slides were analyzed using the criteria described by Nugent et al. (23) , which applies a scoring system for the presence of bacterial morphotypes of normal microbiota, a score of 4-6 consisted of moderately disturbed microbiota, and a score equal or greater than 7 consisted of bacterial vaginosis (BV).
Statistical analysis
The association between cervical lesions, genital infections, MMP-9 and RECK expression was evaluated by odds ratio (OR) with a 95% confidence interval (CI). The social and demographic characteristics were evaluated by Chi-square test.
Multiple logistic regression analysis was used to calculate the odds ratios adjusted for the control variables, such as age, age at first sexual intercourse, ethnicity, parity, smoking and genital infections. The statistical analyzes described above were performed using the software SAS version 9.1.3 (SAS Institute, Cary, NC, EUA). The RT-qPCR gene expression of MMP-9 and RECK data was evaluated by Student's T test, using GraphPad Prism version 5.0 (GraphPad Software, San Diego, CA, EUA). Significance level was defined at 5% for all statistical analysis.
Results
In the present study, the mean age of women was 35.4 + 10 years in the case group (CIN2/CIN3/SCC) and 35.8 + 8 years in the control group (no neoplasia/CIN1), with no statistical difference between the two groups. The profile of social and demographic characteristics in the study groups is shown in Table 1 . We found a statistically significant higher frequency of smoking women in the case group when compared to the women in the control group (37% vs. 21%, respectively; p=0.001). We also found a higher frequency of women having had first sexual intercourse at age below 15 years in the study group (44%) when compared to the women in the control group (30%), and this difference was statistically significant (p=0.008). 
We were able to gather data on a large spectrum of diagnosed genital infections from 300 women, by GRAM and M-PCR techniques. The most prevalent genital infection was BV (23%), followed by C. trachomatis (11%), Trichomonas vaginalis (3%) and Candida spp (3%). Neisseria gonorrhoeae was detected in four women (1.3%), while HSV1, HSV2 and Treponema pallidum were identified in two women each (0.9%). One case of Treponema pallidum was associated with an infection by C.
trachomatis.
The overall frequency of HPV was 52% (166/320). Of the 166 positive cases, 32% presented multiple HPV infections and 68% presented a single infection. We detected 32 different types of HPV. The most prevalent type detected was HPV16 (34%), followed by HPV31 (8%), HPV52 (7%), HPV33 (6.5%), HPV58 (6%), HPV35 (5.5%), and HPV62 (4%). HPV18 represented 2.6% of the cases. In the case group (CIN2/CIN3/SCC), the frequency of HPV was 89%, while in the control group (no neoplasia/CIN1) the frequency was 24%. Regarding the oncogenesis risk of HPV, 91% of the HPV-positive cases were high-oncogenic risk types, 7% were low-oncogenic risk types and 2% were probably oncogenic.
With regard to the phylogenetic distribution of HPV, infection by alpha-9 species (which includes HPV types 16, 31, 33, 35, 52, 58) occurred in 75% of the cases, and infection by alpha-7 species (HPVs 18, 39, 45, 56, 59, 66, 68) occurred in 9% of the cases, while a combination of these two species was found in 5% of all cases. Other HPV species were inexpressively detected such as alpha-5, alpha-6, alpha-11 and alpha-15.
The relationship of the HPV status with the MMP-9 and RECK expression is shown in Table 2 , while the relationship between HPV and other infectious agents is represented in Table 3 . We demonstrated that the presence of HPV, especially HPV16 and other alpha-9 HPV types, was significantly associated with increased expression of MMP-9 and low expression of RECK ( Table 2) . Women infected by C. trachomatis were more likely to have a moderate/accentuated MMP-9 expression, which was about 2.6 times higher than the cases negative for C. trachomatis, with statistically significant results even after adjusting for the presence of HPV (OR= 2.6; 95%CI: 1.1-6.7).
Furthermore, women with C. trachomatis had a higher prevalence of HPV multiple infection (OR= 2.7; 95%CI: 0.8-9.0). We also found a statistically significant association between C. trachomatis and high-grade cervical disease (CIN2/CIN3/SCC) when compared to the control group, i.e. no neoplasia/CIN1 cases (OR=3.7; 95%CI:
1.1-4.9). However, this association was not seen for BV or other genital infections in general ( Table 3) When we considered only women infected by high-risk HPV, we found that frequency of moderate/accentuated MMP-9 expression in women with concomitant infection by C. trachomatis was higher (17%) when compared to negative-mild MMP-9 expression (6%), although this result was not statistically significant (OR=3.3; CI 95%: 0.7-15.8). Moreover, frequency of moderate/accentuated RECK expression in C. trachomatis positive samples is lower (7%) when compared to negative-mild RECK expression (16%), but this difference was also not significant (OR= 0.4; CI 95%: 0.7-
1.7) (data not shown).
One important finding reported in Table 4 is that women from the case group (CIN2/CIN3/SCC) had a greater frequency of moderate/accentuated expression of MMP-9 than the women in the control group (no neoplasia/CIN1) and this association was statistically significant (OR= 4.2; 95%CI: 2.2-7. already been amply demonstrated in the literature (13) (14) (15) (16) . Additionally, we found that women with C. trachomatis have a 2.7 higher chance of presenting multiple infections 
carcinogenesis.
In addition to genital infections, behavior and physiological characteristics such as smoking, parity, oral contraceptives, alcohol and age at first sexual intercourse have been described as factors that influence acquisition of HPV and development of neoplastic lesion (35) (36) (37) (38) . In this context, we found a higher frequency of smoking patients in the study group when compared to the control group. In fact, a large longitudinal study have reported smoking as a risk factor for CIN3 and invasive cervical carcinoma (38) . The induction of epigenetic changes could explain this finding, since it has been shown that smoking increases the risk of methylation of the tumor suppressor gene CDKN2A (p16), an epigenetic inactivation strongly associated with the pathogenesis of malignancies (39) .
In this study, the frequency of women having had first sexual intercourse at age below 15 years was significantly higher in the study group (44%) when compared to the control group (30%). Our data are in agreement with the literature, once sexual precocity is known to increase susceptibility to the first HPV infection, as well as exposure to the carcinogenic effects of HPV, which is associated with higher risk of CIN3 (35, 36, 40) . On the other hand, CIN1 is associated to recent acquisition of HPV infection, regardless of the age of first sexual intercourse (36).
In conclusion, our results show that higher expression of MMP-9 and lower expression of RECK is associated with high-grade cervical intraepithelial neoplasia.
Moreover, we show that MMP-9/RECK imbalance is significantly associated with genital infection by C. trachomatis and infection by alpha-9 HPV, which includes 
